Brandy Fidler

Managing Editor, Digital Content and Life Science at Informa Connect

Featured in: Favicon

hartenergy.com Favicon

midstreambusiness.com Favicon

informaconnect.com

Articles

Digital patient engagement changing support programs for better outcomes

3 days ago | informaconnect.com | Brandy Fidler

In a recent webinar, industry experts shared insights on how digital patient engagement strategies are transforming patient support programs. The presentation, featuring Oliver Dunford, vice president of life sciences at Relay Network, and Angela Cornacchia, director of patient experience, patient access services, at Alkermes, revealed data from over 500,000 patient interactions across 26 specialty and rare disease brands.
Americans value pharmacists but don’t leverage their expertise, survey reveals

5 days ago | informaconnect.com | Brandy Fidler

A survey by specialty pharmacy Lumicera Health Services, a subsidiary of Navitus Health Solutions, has uncovered a disconnect between Americans’ concerns about prescription costs and their willingness to seek help about it from pharmacists. The research, conducted in February of 2,000 adults in the US, showed that while most Americans trust their pharmacists, they rarely engage them in conversations about medication affordability.
Building compliance from the ground up: Tim Stow’s vision at Galderma

5 days ago | informaconnect.com | Brandy Fidler

In a sit-down interview at the Pharmaceutical Compliance Congress, Tim Stow, global head of ethics and compliance at Galderma, spoke with Compliance Insider about his extensive experience in the pharmaceutical industry and his current leadership role. Stow brings over 30 years of experience in the life sciences sector to his current position. A lawyer by training, he has built a career trajectory working with numerous healthcare companies around the world.
How AI can become a ‘thought partner’ to compliance programs

1 week ago | informaconnect.com | Brandy Fidler

In a recent webinar, industry leaders discussed applications, challenges, and strategies for implementing AI in compliance programs.
Integration and tech at the forefront of market access, say Eisai and Celcuity

2 weeks ago | informaconnect.com | Brandy Fidler

Access executives from Eisai and Celcuity share insights into developing trends influencing market access strategies. Vertical and horizontal integration, along with consolidation across the healthcare continuum, are some of the emerging trends impacting market access strategies and tools today, according to Nancy Bell, vice president, head of market access, at Celcuity, a clinical-stage biotech company.
Partners in progress: How Novo Nordisk transformed compliance into strategy

3 weeks ago | informaconnect.com | Brandy Fidler

In an era where corporate ethics and business success are often viewed as competing interests, Novo Nordisk has pioneered an approach that positions ethics and compliance as a strategic advantage.
Bridging business and ethics: A pharmaceutical compliance leader’s perspective

3 weeks ago | informaconnect.com | Brandy Fidler

Compliance leadership in pharmaceuticals demands a delicate balance of technical expertise, strategic vision, and ethical stewardship, according to Peter J. Agnoletto, strategic business advisor, General Medicines U.S., at Sanofi. With over two decades of experience in multibillion-dollar international public companies, Agnoletto brings a wealth of knowledge from his roles, including his previous position as chief compliance officer and chief audit executive at Par Pharmaceuticals Companies.
PAN Foundation report shows concerning trends for patient access

1 month ago | informaconnect.com | Brandy Fidler

Amy Niles, the PAN Foundation’s chief mission officer, spoke exclusively with Access Insider about the current state of patient access, the barriers, the value of advocacy, and the need for action.
Better collaboration is needed among patient advocacy groups and biotech

1 month ago | informaconnect.com | Brandy Fidler

In a recent fireside chat at the Rare Disease Summit in Philadelphia, Karin Hoelzer, senior director, patient advocacy at Biotechnology Innovation Organization (BIO), and Tricha Shivas chief strategy officer at the Foundation for Sarcoidosis Research explored the role patient advocacy groups play in accelerating and improving the development of therapies for rare diseases.
Emerging trends shaping pharmaceutical compliance in 2025

1 month ago | informaconnect.com | Brandy Fidler

Proactive compliance within reimbursement hubs, strategic navigation of data purchases, and medical and commercial interactions are among the rising trends in pharmaceutical compliance this year. In a recent webinar, “Pharmaceutical Compliance: Emerging Trends & Best Practices for 2025” webinar, hosted by the Pharmaceutical Compliance Congress in March, a group of compliance experts discussed the latest movements in the industry, offering insights and strategies to implement.